Abstract OBJECTIVES: This study aimed to investigate the safety, feasibility and availability of doubly committed ventricular septal defect (DCVSD) closure via an ultraminimal intercostal incision under the guidance of transoesophageal echocardiography in children.
INTRODUCTION
The spontaneous closure of a doubly committed ventricular septal defect (DCVSD) is very rare [1] . DCVSDs are prone to develop aortic valve prolapse (AoVP) or aortic regurgitation (AR) due to a lack of support for the right aortic leaflet [2] and shock resulting from high blood flow [3] . Therefore, DCVSDs should be closed as soon as possible [1] .
Conventional DCVSD repair under direct visualization with a cardiopulmonary bypass is effective but causes considerable trauma. The percutaneous closure of a perimembranous ventricular septal defect (VSD) has the advantages of causing less trauma and resulting in a good outcome and quick recovery [4, 5] . However, the percutaneous closure of a DCVSD is difficult to perform [6] and has a high failure rate [2] . Transcatheter closure is a complicated approach requiring an arterio-venous guide wire loop; this procedure cannot be performed in patients with low body weight or vascular access problems. Another disadvantage of the percutaneous closure technique is that it exposes patients to radiation [7] [8] [9] [10] . Recently, the minimally transthoracic closure of VSDs under the guidance of transoesophageal echocardiography (TOE) has been developed [11] [12] [13] [14] [15] [16] to treat DCVSDs [17] [18] [19] ; compared with the percutaneous approach, this procedure has the advantages of a short delivery path, no radiation injury and no restriction on weight or vascular access. However, the approach requires a sternum incision, which can easily lead to bleeding, pain and pectus excavatum [15] . The incision length averages 3-4 cm, and scarring of the incision affects patients' cosmetic appearance. Moreover, DCVSDs are located just below the aortic and pulmonary valves [18] , and the lower sternal incision is separated from the DCVSD. Technically, this approach is not considered an ideal minimally invasive surgery.
On the basis of the minimally invasive transthoracic closures of more than 900 patients, we modified the approach using a left parasternal ultraminimal intercostal incision. With an ultraminimal incision and a pericardium hanging technique, DCVSD closure using an eccentric occluder has been successfully implemented in children. In this study, we aimed to investigate the safety, feasibility and availability of this new surgical approach.
MATERIALS AND METHODS

Patient inclusion
A total of 35 children who underwent DCVSD closure via an ultraminimal intercostal incision between August 2014 and August 2016 were included in this study. Transthoracic echocardiography (TTE), electrocardiograms and X-rays were performed before surgery. TTE was used to measure DCVSD size and assess the condition of the aortic and pulmonary valves. Five patients had mild AR in this study. Informed consent was obtained from all the guardians of the patients.
The inclusion criteria were as follows: DCVSD located at the 12:00 to 1:30 o'clock position in the parasternal short-axis view on TTE, diameter < _5 mm, no AR and mild AoVP and AR with a perfect closed point. The exclusion criteria were as follows: DCVSD with a diameter >5 mm, moderate-to-severe AoVP or AR, severe pulmonary hypertension and other heart diseases; other surgical contraindications.
Surgical procedures
Device selection. After the children were anaesthetized in the operating room, TOE was performed to measure the size of the DCVSD and to assess the integrity of the aortic and pulmonary valves. A proper eccentric occluder was chosen according to the TOE examination results. Normally, the size of the device is approximately 2 mm larger than the maximum diameter of the defect.
Device and delivery system. The closure device and delivery system used in this study was a domestic eccentric occluder (Shanghai Shape Memory Alloy Co., Ltd, Shanghai, China). The left disc of the eccentric occluder exceeds the connecting waist by 0 mm in its superior aspect and by 4.0 mm in its inferior aspect (mark). The right disc is 2 mm larger than the waist in both parts of the device. The waist is 3.5-4.0 mm in diameter. The delivery system is mainly composed of a long delivery sheath, a short loading sheath and a delivery cable (Fig. 1) . Prior to use, the selected eccentric occluder must be soaked in heparin saline, and the delivery system must be washed with heparin saline. The occluder was screwed onto the delivery cable to be inserted into the loading sheath. Then, the device must be examined prior to the operation by pulling back and pushing forward to release it from the sheath. A protective suture of 3-0 polypropylene passing through the mesh of the right disc near the middle was added to the device.
Procedure. TTE was used to determine the position of the ultraminimal intercostal incision based on the location of the DCVSD and the direction of blood flow. The incision was commonly made in the left sternal margin at the third intercostal space. An incision less than 1 cm in length (the smallest incision in this study was 0.7 cm) was made. Superficial tissues were opened with blunt dissection without entering into the pleural cavity. The pericardium was incised transversely and hung with 4-5 sutures (Fig. 2) . With the real-time guidance of TOE, the position of the purse-string suture on the right ventricular surface was determined using tweezers under direct visualization. When the tweezers' head was vertically pointed towards the DCVSD, a purse-string suture was made at the position of the tweezers'
head. An optimal angle from the selected site towards the VSD facilitated the insertion of the guide wire through the VSD.
After heparin (0.5 mg/kg) was administered, a punch needle was inserted into the right ventricle. Then, the guide wire was inserted into the DCVSD. The punch needle was withdrawn, and the delivery sheath was introduced to the left ventricle over the guide wire. Although the tip of the sheath was confirmed to be in the left ventricle, the surgeon withdrew the guide wire and the dilator. The short loading sheath was then connected to the long delivery sheath. TOE was placed at approximately 110 (in the left ventricular long-axis view) for real-time monitoring and guidance, whereas the surgeon pushed the occluder and released the left disc. It is important to verify that the mark appears clearly distant from the aortic valve to avoid interfering with the movement of the valve. If the device was not in the right position, the occluder could be gently rotated clockwise through the delivery cable and then adjusted to a precise location until no AR exists. Then, the sheath was withdrawn further back towards the right ventricle, and the waist of the device and the right disc were completely released (Fig. 3) .
TOE was performed. The occluder was adjusted, withdrawn or replaced if complications such as device dislocation, residual Figure 1 : (A) From top to bottom, the delivery system includes a delivery cable, a short loading sheath, a long delivery sheath and a dilator. (B) The eccentric occluder was screwed onto the delivery cable, which travelled to the short loading sheath. The left arrow indicates the spot where the device-protective suture was passed through the mesh of the right disc; the middle arrow indicates where the device-protective suture was placed in the short loading sheath and the right arrow indicates where the device-protective suture was pulled out of the short loading sheath. (C) The eccentric occluder was pulled into the short loading sheath to show only a mark (large arrow). The small arrow indicates where the device-protective suture was pulled out of the sheath.
shunt, device-related aortic or pulmonary regurgitation or outflow tract obstruction were found. The device was inspected repeatedly by a push-pull manoeuvre and released only when it was in its proper position with no complications.
After the occluder was released, the protective device suture aided in the retrieval of the device through a larger delivery sheath if the device was found to be displaced by TOE [2] . If conditions were normal, the suture could be gently pulled out from the device. Then, the delivery device was removed, and the purse-string suture was ligated. A percutaneous ArrowV R venous catheter was placed in the pericardial cavity for drainage; 3 holes one-third the size of the catheter diameter were made on the intrapericardium segment of the catheter. The incision was closed in layers.
During the operation, patients were closely monitored for heart rate, blood pressure, oxygen saturation, blood gas analysis and airway management; monitoring was comparable to that accompanying any open-heart surgery. The procedure should be discontinued if these indications were abnormal. If severe complications occur, the procedure should be immediately converted to surgical repair under cardiopulmonary bypass.
Key points. When planning to close DCVSDs via ultraminimal intercostal incisions under TOE guidance, the following issues should be addressed. First, to ensure that the operation is performed smoothly, the ultrasound doctor and the surgeons should work closely as a team; all members of the team should know what is happening and notify each other immediately when the situation changes. Second, skilful surgical technique is important for a successful procedure. The accumulation of experience is very important. Third, preoperative TOE must be performed carefully. According to the inclusion criteria, patients will be reevaluated by TOE in the operating room, and the doctors will discuss their choice of an optimal closure device. A large occluder might cause valve damage, and a small occluder could cause device dislocation or a residual shunt. Fourth, the positions of the intercostal incision and the purse-string suture should be selected very carefully, because an ultrasmall incision could limit the range over which the guide wire and sheath could move. Using both TTE and TOE, the correct location of the incision and the purse-string suture can be selected accurately, which will greatly increase the success rate of device closure and reduce the operative duration and risk of surgery. Fifth, tweezers should not be used to repetitively clamp to avoid damage to the right ventricular surface when the position of the purse-string suture is determined using the tweezers. Sixth, the device-protective suture should be used for all patients. The suture cannot entwine the delivery cable as it is pulled out of the sheath, thereby improving the safety of this technique. Seventh, the incision should not be made too close to the left sternal margin to avoid injury to the left internal mammary artery [2] .
Follow-up
All patients were followed up. TTE, electrocardiograms, X-rays and blood tests were used to assess surgical outcomes. The follow-up examinations assessed heart function, heart rhythm, occluder placement, residual shunt, valve regurgitation, infective endocarditis, thrombus and pericardial effusion.
Statistical analysis
Data on age, weight, DCVSD size and procedure time were normally distributed and were expressed as the mean ± standard deviation and range, as appropriate. Data on device size and length of hospital stay were non-normally distributed and were expressed as the median ± interquartile range and range, as appropriate. All data were analysed using SPSS 19.0 statistical software.
RESULTS
Clinical data and outcomes for all the 35 patients are listed in Table 1 . All patients had complete closures with an operation success rate of 100%. Correct placement of the device on the first attempt was achieved in 32 (91.43%) patients; in 3 patients, a second attempt was performed to replace the small device with a bigger one due to the presence of a residual shunt around the occluder device. Five patients were diagnosed as having DCVSD with mild AoVP and AR before the surgery; all operations were performed smoothly, and no aggravation of AR was found during the operations. Heart function was good in all patients, and no blood transfusions, serious arrhythmias or death occurred. There were no dislocated devices, residual shunts, device-related valve regurgitation or outflow tract obstruction during the operation. Mild pericardial effusion was found in 1 patient after the operation and disappeared over the course of the 3-month follow-up period.
All patients were followed up for a period ranging from 6 months to 2.5 years (median 17 months) after the operation. Follow-up examinations showed good placement of the occluder, good heart function, no residual shunts, no arrhythmia, no infective endocarditis and no thrombus. Pre-existing AR disappeared after surgery in 1 patient and remained the same in 4 patients. Device-related AR and pulmonary regurgitation were not found.
DISCUSSION
In this study, we used an eccentric occluder to close DCVSDs (< _5 mm) via ultraminimal intercostal incision under TOE guidance. To the best of our knowledge, this approach is a novel strategy for the treatment of DCVSD.
Application of an eccentric occluder device enables DCVSD closure using an occluder via an ultraminimal incision. The eccentric occluder device can avoid the aortic valve and pulmonary valve trauma caused by the placement of a concentric occluder [2, 18, 19] . Pointing the superior part of the left disc towards the aortic valve can prevent impairment of aortic function. The right disc of the device is separated from the pulmonary valve, because left ventricular pressure is higher than right ventricular pressure after the VSD is occluded. Therefore, the area contacting the pulmonary valve is the waist but not the rim of the right disc of the occluder. The pulmonary annulus is slightly higher than the aortic annulus [2] . These features greatly decrease the risk of impairment of the pulmonary valve. Without the aortic and pulmonary rim, the circumferential rim can provide sufficient support to the occluder in small DCVSDs [2] . DCVSDs with a small teardrop-shaped mild AoVP and mild AR [20] were not considered a contraindication for this procedure [2] . Small DCVSDS allow for greater shunt velocities and thus greater force pulling the aortic cusp into the VSD [3] . Over time, the aortic cusp elongates to cause AoVP and AR. After successful DCVSD closure, AoVP and AR may not be exacerbated because there is no shunt to interfere with the aortic valve.
Compared with the transcatheter closure approach, the operation duration of the ultraminimal intercostal incision closure approach is shorter [4, 6] . This novel approach has a short delivery path and does not require the establishment of an arteriovenous guide wire loop through the aorta and the aortic valve. Moreover, TOE [16] can clearly detect the guide wire, sheath and occluder to provide real-time guidance that enables cardiovascular surgeons to operate smoothly. The distance from the intercostal incision to the DCVSD is shorter, and the plane of the DCVSD lies almost perpendicular to that of the remainder of the septum. Thus, the delivery sheath is more perpendicular to the DCVSD, resulting in easier and more accurate device positioning [2] . As in the transcatheter procedure, no blood transfusion is necessary in this novel approach.
The ultraminimal intercostal incision (< _1 cm) avoids the need for a sternal incision and leads to minimal scarring. The use of the pericardium hanging technique instead of retractor devices for exposure can avoid injury to the ribs and the intercostal tissue.
When an occluder closure fails, the procedure must be converted to an open-heart surgical repair. After surgical repair, the presence of both a long and a short incision may affect the patient's appearance.
Limitations
This study is limited by the fact that it is a single-centre study with a small sample size and a short follow-up period. We reported only 35 patients successfully treated using this approach. Further studies are required to establish long-term follow-up results in a larger patient population. The age range of the 35 children in this study was 13 months to 72 months; patients in other age groups must be studied.
CONCLUSION
In conclusion, DCVSD (< _5 mm) closure via an ultraminimal intercostal incision under TOE guidance is effective, feasible, safe and simple. Surgical complications are rare. Therefore, this approach can be considered an alternative treatment to open-heart surgery for selective DCVSDs.
